In this video

Share

Watch CNBC's full interview with Sarepta CEO Doug Ingram

Doug Ingram, Sarepta Therapeutics CEO and president, sits down with CNBC's Meg Tirrell at the J.P. Morgan health care conference to discuss the company's gene therapy potential.
03:55
Tue, Jan 14 20201:34 PM EST